Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol-Reference-Cited by-同舟云学术

Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol

Published:2024-04 Issue: Volume:39 Page:100875
ISSN:2666-7762
Container-title:The Lancet Regional Health - Europe
language:en
Short-container-title:The Lancet Regional Health - Europe

Author:

Verkerk Karlijn,Geurts Birgit S.,Zeverijn Laurien J.,van der Noort Vincent,Verheul Henk M.W.,Haanen John B.A.G.^ORCID,van der Veldt Astrid A.M.,Eskens Ferry A.L.M.,Aarts Maureen J.B.,van Herpen Carla M.L.,Jalving Mathilde^ORCID,Gietema Jourik A.,Devriese Lot A.,Labots Mariette,Barjesteh van Waalwijk van Doorn-Khosrovani Sahar,Smit Egbert F.^ORCID,Bloemendal Haiko J.^ORCID

Funder

Roche

Sanofi US

Novartis Pharmaceuticals Corporation

Janssen Pharmaceuticals Inc

Merck KGaA

Eli Lilly and Company

Bayer AG

Publisher

Elsevier BV

Reference24 articles.

1. Real-world data: towards achieving the achievable in cancer care;Booth;Nat Rev Clin Oncol,2019

2. Harmonising patient-access programmes: the Dutch DRUG Access Protocol platform;Zeverijn;Lancet Oncol,2022

3. Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging;Que;J Am Acad Dermatol,2018

4. Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing;Rischin;J Immunother Cancer,2020

5. Samenvatting plaveiselcelcarcinoom: NVDV;Dekker,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient cytosolic delivery of proteins enabled by modular fusion protein;Chemical Engineering Journal;2024-10

2. Generating and using real-world data: A worthwhile uphill battle;Cell;2024-03